Primary evaluation on immunogenecity of enterovirus 71 and hepatitis B combined vaccine
CHEN Meng-jiao;YANG Xiao-lei;LIU Long-ding;ZHENG Hui-wen;LUO Na;YIN Xiao-xiao;LI Hong-zhe;DENG Yan;LI Zai-han;SUN Ming-bo;YANG Jing-si;Institute of Medical Biology;Chinese Academy of Medical Sciences and Peking Union Medical College;

..............page:329-333+338

Stability of thimerosal-free influenza virus split vaccine
ZHAO Da-peng;YAO Wei-min;GU Li-juan;SUN Li-juan;SUN Yu;GUO Xue;YANG Xu;CHEN Zhong-qiang;SHANG Feng-yun;FAN Yu-hong;WANG Ya-jun;ZHANG Xue-mei;Changchun Institute of Biological Products Co.;Ltd.;

..............page:334-338

Expression of human immunodeficiency virus type 1 Vpu protein in Pichia pastoris and purification of expressed product
WANG Jiao;LIU Wei;HU Qin;LI Ze-lin;ZENG Yi;College of Life Science and Bioengineering;Beijing University of Technology;

..............page:339-343

2015 zhong guo ( nan jing ) guo ji sheng wu yi yao chan ye bo lan hui

..............page:343

Effect of chondroitin sulfate B adjuvant on humoral immune response induced by hepatitis A virus vaccine in mice
WANG Chen-yun;SUN Jing;LI Ping;YU Bing-ting;LI Jian-fang;LI Yan-han;WANG Hai-xuan;WU Mei-ni;HU Ning-zhu;HU Yun-zhang;Institute of Medical Biology;Chinese Academy of Medical Science and Peking Union Medical College;Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases;Yunnan Research Center of Engineering Technique for Vaccines against Severe Infectious Diseases;

..............page:344-347

huan ying deng lu zhong guo sheng wu zhi pin xue za zhi wang zhan

..............page:347

Construction of eukaryotic expression vector for suppressor of cytokine signaling 1 and its expression in NOK cells
XU Ya-xin;WU Bin;YOU Jin-mei;LI Yu;YANG Yong;CHEN Xian-jiu;Department of Epidemiology;Shanxi Medical University;

..............page:348-351

Prokaryotic expression,purification and stability of recombinant human prolactin protein
LIU Xiao-lei;ZHANG Hui-li;WANG Jun-shan;HAN Jing;CHANG Li-qing;LU Kun;WANG Zhan-zheng;Zhengzhou Biocell Biotechnology Co.;Ltd.;

..............page:352-355

Cloning and prokaryotic expression of allophycocyanin α and β subunit genes of Spirulina platensis
JIANG Xiao-jie;GAO Jin-liang;QI Mei-rong;XU Meng-jie;WANG Wen-jie;LI Wei;Ordos Municipal Center for Disease Control and Prevention;

..............page:356-359+363

Screening of stabilizer for pandemic influenza vaccine
ZHOU Qing-ling;YU Jing;XIE Ying-lin;LI Chun-yan;HAN Yun-fei;LI Yang;DONG Huan;YUE Zhen-qi;WANG Yi-ming;HU Xiao-ming;GUAN Hong-chao;YU Hong-tao;Center of Development of Drugs;Jilin Yatai Co.;Ltd.;

..............page:360-363

Cloning,prokaryotic expression and purification of human annexin A3
WANG Bing;GAO Ping;NIU Cheng-cheng;LI Shan-yu;Department of Pediatrics;First Hospital of Jilin University;

..............page:364-367+371

Protective effect of piceatannol and acetylated resveratrol on radiation damage in mice
WANG Chun-yan;QI Xue-song;TONG Peng;HAO Shu-xia;LV Hui-min;GOU Qiao;National Institute for Radiological Protection;Key Laboratory of Radiological Protection and Nuclear Emergency;Chinese Center for Disease Control and Prevention;

..............page:368-371

Expression and purification of pneumococcal surface protein A and preparation of its polyclonal antibodies
XU Yue-yue;CAI Ran;MA Ying;SHANG Yan-hong;YUAN Jing-yu;ZHANG Su-fen;LI Yue-xi;Department of Biochemistry and Molecular Biology;College of Basic Medicine;Nanjing Medical University;

..............page:372-376+382

Clinical trial of booster immune effect of inactivated tick-borne encephalitis vaccine
HE Shu-yun;WANG Yi-wen;QIAO Jian-guo;FU Bo;FAN Xue-bin;JIANG Wei;Center for Disease Prevention and Control of Jilin City;

..............page:377-378

Surveillance of adverse events following immunization with measles-containing vaccine in Hongkou District,Shanghai,2009~2013
YANG Yan-ji;QIAN Xiao-hua;HUANG Yang;Shanghai Hongkou Center for Diseases Control and Prevention;

..............page:379-382

Safety and effectiveness of two kinds of hepatitis A vaccine in Baoding City, Hebei Province, China
ZUO Zhi-ping;Baoding Municipal Center for Disease Control and Prevention;

..............page:383-384+389

Determination of endotoxin content in final product of diphtheria, tetanus and acellular pertussis combined vaccine, adsorbed
WEI Chen;PEI Yu-sheng;CHAO Zhe;LUO Peng;TAN Ya-jun;WANG Li-chan;MA Xiao;HOU Qi-ming;Division of DTP and Toxins;National Institutes for Food and Drug Control;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Product;

..............page:385-389

Development of nuclear magnetic resonance method for analysis of chemical structure of groups C, Y and W135 Neisseria meningococcal capsular polysaccharides
LI A-ni;YU Xu-bo;LUO Shu-quan;HU Hao;KONG Su-juan;YUAN Fei;YANG Ying-ying;LIU Fang-lei;WU Bing;CHEN Zuo-jiang;ZHAO Zhi-qiang;XIE Gui-lin;Lanzhou Institute of Biological Products Co.;Ltd.;

..............page:390-397

Determination of virus titer of live attenuated hepatitis A vaccine by integrated cell culture / strand-specific RT-PCR
;XIA Qing-juan;XU Yan-ling;LI Shu-lin;CHU Dong-lin;HOU Li-juan;WENG-Bin;XIAO Xiang;QIU Lu;XU Xiao-xia;LIU Ling-jiu;Changchun Institute of Biological Products Co. Ltd;

..............page:398-401

Development and verification of a method for determination of free polysaccharide content in meningococcal polysaccharide-diphtheria toxoid(CRM197)conjugate
ZHU Tao;ZHU Wan-yu;YU Xue-feng;MAO Hui-hua;SHAO Zhong-qi;Tianjin University of Science and Technology;

..............page:402-405+410

Optimization and validation of kinetic chromogenic method for determination of α1-protease inhibitor activity in human plasma
ZHOU Yan-xiang;ZHOU Zhi-jun;LIN Lian-zhen;PENG Yan;ZOU Li;HU Yong;ZOU Wei;LI Ce-sheng;Wuhan Institute of Biological Products Co.;Ltd.;

..............page:406-410

Development and verification of a method for determination of sucrose content in Haemophilus influenza type b conjugate vaccine
YANG Ye;LIAO Dan;XIE Shan-shan;LI Qing-yun;WANG Jing;Chengdu Institute of Biological Products Co.;Ltd.;

..............page:411-413+417

Development of a method for determination of biological activity of anti-epithelial growth factor receptor monoclonal antibody
LIU Pei-pei;LIAO Hui-hui;LIU Wei-xu;CHEN Xiang;TAN Qing-qiao;Department of Analytical Science;Shanghai CP Guojian Pharmaceutical;Co.;Ltd.;

..............page:414-417

Development and verification of spectrophotometry for determination of catalase activity
LIAO Dan;YANG Ye;LI Qing-yun;XIE Shan-shan;WANG Jing;Chengdu Institute of Biological Products Co.;Ltd;

..............page:418-421+425

Development and application of double antibody sandwich Dot-ELISA for Neospora caninum infection in deer
TIAN Lai-ming;YANG Bin-tong;LI Zhi-peng;ZHANG Tong-jia;GONG Peng-tao;LI Jian-hua;WANG Quan-kai;YANG Ju;LI He;ZHANG Xi-chen;College of Veterinary Medicine;Jilin University;

..............page:422-425

Determination of residual methylene blue in plasma after virus inactivation
YANG Chun-hui;BIAN Guo-hui;YANG Hong;LIANG Qi-zhong;ZHOU Qun-gang;LI Chang-qing;Institute of Blood Transfusion;

..............page:426-428+437

Advance in research on method for screening of aptamers
XU Long-feng;WANG Li;College of Food and Drug;Anhui Science and Technology University;

..............page:429-433

2001~2010 nian gui ping shi kuang quan bing liu xing qu shi fen xi
yi ming you ; yu cui xia ;

..............page:434-437

bai hou xiang guan yi miao guan jian zhi liang can shu de bi jiao
dong guo xia ; tian lin ; tan ya jun ; hou qi ming ; ma xiao ;

..............page:438-440